Ilex Medical

Ilex Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ilex Medical (ILX.TA) as of Oct 22, 2026 is 81.51 M ILS. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 97.16 M ILS — a change of -16.11% (lower).

EBITDA

81.51 MILS

YoY

-16.11%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ilex Medical is 2024 81.51 M ILS. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ilex Medical was 2023 97.16 M ILS. It decreases by -16.11% lower compared to the previous year.

The Ilex Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
61.26 M ILS
Jan 1, 2018
83.83 M ILS
Jan 1, 2019
99.85 M ILS
Jan 1, 2020
165.54 M ILS
Jan 1, 2021
272.07 M ILS
Jan 1, 2022
156.50 M ILS
Jan 1, 2023
97.16 M ILS
Jan 1, 2024
81.51 M ILS
The Ilex Medical EBITDA history
YEAREBITDAYoY
81.51 MILS-16.11%
97.16 MILS-37.92%
156.50 MILS-42.48%
272.07 MILS+64.36%
165.54 MILS+65.79%
99.85 MILS+19.10%
83.83 MILS+36.85%
61.26 MILS+6.17%
57.70 MILS-9.42%
63.71 MILS+22.80%
51.88 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ilex Medical is 81.51 M ILS in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ilex Medical changed from 97.16 M ILS to 81.51 M ILS, representing a -16.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ilex Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Ilex Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Ilex Medical